Patent · US Active

Luminescence characterization of quantum dots conjugated with biomarkers for early cancer detection

US7655479B2 · kind B2 · utility

11Cited by
3References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 30, 2005
Grant dateFeb 2, 2010
Priority date
Expiry dateNov 26, 2026

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/588
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Luminescent semiconductor quantum dots (QDs) conjugated with biomolecules to serve as sensitive probes for early detection of the cancer cells, specifically for ovarian cancer and lung cancer, which represents the most lethal malignancies. The luminescence characterization of the bin-conjugated QDs with cancer specific antigens using linkage molecules. Photo-enhancement is measured at various laser density power, temperatures and laser wavelengths.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.